Therapeutic Efficiency of Nasal Mucosa-Derived Ectodermal Mesenchymal Stem Cells in Rats with Acute Hepatic Failure

BACKGROUND: Liver transplantation is limited by the insufficiency of liver organ donors when treating end-stage liver disease or acute liver failure (ALF). Ectodermal mesenchymal stem cells (EMSCs) derived from nasal mucosa have emerged as an alternative cell-based therapy. However, the role of EMSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Wen, Wang, Xinhe, Yu, Xinghui, Xie, Yan, Zhang, Li, Lu, Naiyan, Jiang, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842420/
https://www.ncbi.nlm.nih.gov/pubmed/36655034
http://dx.doi.org/10.1155/2023/6890299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842420/
https://www.ncbi.nlm.nih.gov/pubmed/36655034
http://dx.doi.org/10.1155/2023/6890299

Ejemplares similares